Recent Advances in Migraine Preventive Treatment
Overview of Migraine Disorder
Migraine is a chronic condition marked by recurring, debilitating headaches that significantly impact the quality of life for those affected. Traditional medications aimed at reducing the frequency and intensity of migraine attacks often face challenges related to effectiveness, safety, and side effects.
Promising Treatment Methods
A review published in BMC Medicine highlighted two innovative treatment approaches currently undergoing testing in human clinical trials.
Antibody-Based Therapies
Four pharmaceutical companies from the US, UK, and Israel are investigating the use of antibodies that target a specific protein on nerve cells involved in pain transmission. Recent clinical trial results indicate that these antibodies effectively reduced the monthly incidence of migraines in treated patients after just four weeks compared to those receiving a placebo. Notably, no serious adverse reactions were reported during these trials. Ongoing studies with larger patient groups aim to further evaluate the efficacy and safety of this antibody-based therapy in comparison to existing migraine prevention methods.
Neurostimulation Techniques
In addition to antibody therapies, three companies are exploring a non-invasive neurostimulation method for migraine prevention. This technique employs electrodes to deliver electric pulses that stimulate brain nerves, effectively disrupting pain signals. Preliminary findings suggest that daily neurostimulation over a three-month period led to a reduction in the number of monthly migraines for patients. The method has proven to be safe, with no serious adverse events noted during the study, making it a potential alternative for migraine sufferers who experience challenges with oral medications.
Future Outlook
While the long-term effects of these emerging therapies remain to be fully understood, recent advancements in migraine prevention present a promising avenue for developing more effective and safer treatment options for patients.
Reference
Mitsikostas DD and Rapoport AM. New players in the preventive treatment of migraines. BMC Medicine. 2015; 13:279. Doi: 10.1186/s12916-015-0522-1
Author
Written by Ana Victoria Pilar